Jones Kenneth T - Insider Non-Derivative Transactions at Zynerba Pharmaceuticals, Inc. (ZYNE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Oct 10, 2023, Jones Kenneth T's relationship to Zynerba Pharmaceuticals, Inc. (ZYNE) is Officer (See Remarks), and currently has 75,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ZYNE insiders.
Data Source: SEC.
Jones Kenneth T - Insider Non-Derivative Transactions of ZYNE Common Stock
Jones Kenneth T - Insider Non-Derivative Transactions at ZYNE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Oct 11, 2023 | U -- (Common Stock) | 75000 | 0 | 0 |
| Oct 11, 2023 | U -- (Common Stock) | 40520 | 0 | 45000 |
| Oct 11, 2023 | Acquisition -- (Common Stock) | 30000 | 0 | 75000 |
| Sep 14, 2023 | Sell -- (Common Stock) | 2505 | 1.33 | 85520 |
| Sep 13, 2023 | Acquisition -- (Common Stock) | 9000 | 0 | 88025 |